drugset / Trial / NCT03777605

Absorption and Pharmacokinetics of Nitroglycerin to a New Formulation

NCT03777605

Phase 4 Unknown 10 enrolled Kolding Sygehus
NaSingle-groupOpen-labelTreatment

Summary

The study evaluate the absorption rate of different sublingual formulation of nitroglycerine (NTG) either in the form of available tablets or a new rapid absorbable gelation capsule formulation "NTG1523" by determining T-max and area under the response curve of nitoglycerine in blood concentration as well as from clinical effects after intake. Data is entered on data sheet in anonymous form and processed. The results are presented in anonymous form by publication and lecture. Experts are given the supplement: "The applicant's rights in a biomedical research project

Timeline

Start
2018-12-23
Primary completion
2020-12-05
Completion
2020-12-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitroglycerin Unknown 0.4 mg Other